Trial Profile
Assessing the Efficacy of DuoTrav (Travoprost 0.004%/Timolol 0.5% Fixed Combination), as a Replacement Therapy in Glaucoma Patients in Russia, Previously on Prior Prostaglandin Analogue or Beta-blocker Monotherapy
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 27 Apr 2015
Price :
$35
*
At a glance
- Drugs Travoprost/timolol (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Alcon
- 27 Apr 2015 New trial record